tailieunhanh - Avelumab in metastatic collecting duct carcinoma of the kidney: A case report

Collecting duct carcinoma (CDC) of the kidney is associated with an aggressive course, limited response to treatment, and poor prognosis. Platinum-based chemotherapy is currently recommended as the first-line treatment in patients with metastatic CDC. Accumulating evidence supports the use of immunotherapy with checkpoint inhibitors as second-line therapy. |

TÀI LIỆU LIÊN QUAN